Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate that persons over the age of 13 years can obtain a self-collected nasal swab reliably and safely for subsequent use in the diagnosis of influenza. Similarly, the purpose is to demonstrate that parents or guardians can safely and effectively collect nasal swab specimens from children, ages 0 through 12 years, and others needing assistance in doing so, and that these parent/guardian-collected nasal swabs can also be used in the diagnosis of influenza. Clinical performance of the swabs will be based on the comparison of the performance of the nasal swab that is self- or parent/guardian-collected to one collected from the same specimen donor by a skilled clinical coordinator and used in CLIA (Clinical Laboratory Improvement Amendments)-waived, rapid diagnostic test called Sofia Influenza A+B FIA (fluorescence immunoassay analyzer).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03813966
Study type Observational
Source University of Wisconsin, Madison
Contact
Status Completed
Phase
Start date February 7, 2019
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Completed NCT05869201 - Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine Phase 2/Phase 3
Recruiting NCT06123936 - Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician N/A
Completed NCT02103023 - Intradermal Influenza Vaccine in the Young Phase 3
Completed NCT05234229 - Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers
Enrolling by invitation NCT04623047 - Infection Watch Study
Not yet recruiting NCT02465190 - Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns in South Africa N/A
Completed NCT05620953 - Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020)
Recruiting NCT05739474 - Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children Phase 3
Active, not recruiting NCT05794412 - Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study
Recruiting NCT05557539 - Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach N/A
Terminated NCT05105191 - Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room N/A
Not yet recruiting NCT06247059 - Reducing Respiratory Virus Transmission in Bangladeshi Classrooms N/A
Not yet recruiting NCT06175468 - Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease Phase 3
Active, not recruiting NCT01666782 - Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy Phase 2
Completed NCT05507567 - Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Challenge Model Phase 2
Active, not recruiting NCT04998344 - An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Bangladesh Phase 4